Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections-Reference-Cited by-同舟云学术

Comparative evaluation of the use of immunoblots and of IgG avidity assays as confirmatory tests for the diagnosis of acute EBV infections

Published:1998-12 Issue:3 Volume:11 Page:161-172
ISSN:1386-6532
Container-title:Journal of Clinical Virology
language:en
Short-container-title:Journal of Clinical Virology

Author:

Schubert Jörg,Zens Wolfgang,Weissbrich Benedikt

Publisher

Elsevier BV

Subject

Infectious Diseases,Virology

Reference42 articles.

1. Avidities of IgG directed against viral capsid antigen or early antigen: useful markers for significant Epstein–Barr virus serology;Andersson;J Med Virol,1994

2. Application of low-avidity immunoglobulin G studies to diagnosis of Epstein–Barr virus infectious mononucleosis;de Ory;J Clin Microbiol,1993

3. Comparative evaluation of three ELISA techniques and an indirect immunofluorescence assay for the serological diagnosis of Epstein–Barr virus infection;Debyser;Clin Diagn Virol,1997

4. A new Combi test for simultaneous detection of antibodies to viral capsid, early and EBNA antigens of Epstein–Barr virus;Dobec;Int J Med Microbiol Virol Parasitol Infect Dis,1993

5. Infectious mononucleosis and related syndromes;Evans;Am J Med Sci,1978

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of atypical serological profiles for Epstein-Barr virus (EBV);Journal of Virological Methods;2024-09

2. Insights into the interplay between Epstein‐Barr virus (EBV) and multiple sclerosis (MS): A state‐of‐the‐art review and implications for vaccine development;Health Science Reports;2024-02

3. Quand un immunoblot EBV est nécessaire pour conclure une sérologie anti-EBV : cas clinique;Annales de Biologie Clinique;2022-07-01

4. High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity;Exploration of Immunology;2022-03-16

5. The challenge of avidity determination in SARS‐CoV‐2 serology;Journal of Medical Virology;2021-02-19